Our research results showed that the expression of ADA protein in T-ALL tumor cells was higher than that in tumor cells from AML patients, suggesting a specific difference in ADA-mediated signal transduction and cytokine secretion between the two types of leukemia. This evidence concerns the gene ADA and neoplasm.